Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Return on Sales (2020 - 2025)

Historic Return on Sales for Fennec Pharmaceuticals (FENC) over the last 6 years, with Q3 2025 value amounting to 0.05%.

  • Fennec Pharmaceuticals' Return on Sales rose 7700.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17%, marking a year-over-year decrease of 1500.0%. This contributed to the annual value of 0.01% for FY2024, which is 7500.0% up from last year.
  • Fennec Pharmaceuticals' Return on Sales amounted to 0.05% in Q3 2025, which was up 7700.0% from 0.33% recorded in Q2 2025.
  • Over the past 5 years, Fennec Pharmaceuticals' Return on Sales peaked at 435.22% during Q2 2021, and registered a low of 94.54% during Q1 2021.
  • In the last 5 years, Fennec Pharmaceuticals' Return on Sales had a median value of 0.16% in 2025 and averaged 35.5%.
  • Examining YoY changes over the last 5 years, Fennec Pharmaceuticals' Return on Sales showed a top increase of 1565300bps in 2022 and a maximum decrease of -3465000bps in 2022.
  • Quarter analysis of 5 years shows Fennec Pharmaceuticals' Return on Sales stood at 76.64% in 2021, then tumbled by -85bps to 11.31% in 2022, then plummeted by -102bps to 0.27% in 2023, then grew by 30bps to 0.19% in 2024, then soared by 74bps to 0.05% in 2025.
  • Its Return on Sales was 0.05% in Q3 2025, compared to 0.33% in Q2 2025 and 0.13% in Q1 2025.